Related Articles
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy Corrigendum in /10.3892/ol.2020.11285
Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer
Dopamine receptor D2 is correlated with gastric cancer prognosis
Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth
Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor